1. Home
  2. CTVA vs CAH Comparison

CTVA vs CAH Comparison

Compare CTVA & CAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corteva Inc.

CTVA

Corteva Inc.

N/A

Current Price

$79.69

Market Cap

44.7B

ML Signal

N/A

Logo Cardinal Health Inc.

CAH

Cardinal Health Inc.

N/A

Current Price

$219.39

Market Cap

51.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTVA
CAH
Founded
1802
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Other Pharmaceuticals
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.7B
51.2B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
CTVA
CAH
Price
$79.69
$219.39
Analyst Decision
Buy
Buy
Analyst Count
17
11
Target Price
$80.13
$230.45
AVG Volume (30 Days)
3.4M
1.4M
Earning Date
05-04-2026
01-01-0001
Dividend Yield
0.92%
0.95%
EPS Growth
23.08
86.96
EPS
1.60
1.88
Revenue
$17,401,000,000.00
$222,578,000,000.00
Revenue This Year
$6.15
$17.38
Revenue Next Year
$3.15
$9.00
P/E Ratio
$49.15
$114.47
Revenue Growth
2.92
N/A
52 Week Low
$53.40
$120.72
52 Week High
$80.91
$233.60

Technical Indicators

Market Signals
Indicator
CTVA
CAH
Relative Strength Index (RSI) 63.12 49.74
Support Level $71.67 $206.07
Resistance Level $80.91 $231.90
Average True Range (ATR) 1.77 4.72
MACD -0.19 -1.46
Stochastic Oscillator 80.40 32.02

Price Performance

Historical Comparison
CTVA
CAH

About CTVA Corteva Inc.

Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.

About CAH Cardinal Health Inc.

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Share on Social Networks: